Quality development in education

The article suggests that people involved in quality development need a specific competence, called quality literacy, in order to successfully improve learning processes. Quality literacy is viewed as a set of competencies that are needed for professional quality development. Quality literacy emphasizes the importance of professionalism as a necessary component for quality development, in addition to structural quality management models. Quality development is a co-production between learners and their learning environment. This means that the educational process can only be influenced and optimized through participation and not steered externally. Quality strategies cannot, therefore, guarantee a high quality of learning processes but rather aim at professionalisation of the educational process. This article suggests participation and negotiation between educational participants (clients and providers) as a main condition for quality development. © 2009 Springer Berlin Heidelberg

Quality development in education

The article suggests that people involved in quality development need a specific competence, called quality literacy, in order to successfully improve learning processes. Quality literacy is viewed as a set of competencies that are needed for professional quality development. Quality literacy emphasizes the importance of professionalism as a necessary component for quality development, in addition to structural quality management models. Quality development is a co-production between learners and their learning environment. This means that the educational process can only be influenced and optimized through participation and not steered externally. Quality strategies cannot, therefore, guarantee a high quality of learning processes but rather aim at professionalisation of the educational process. This article suggests participation and negotiation between educational participants (clients and providers) as a main condition for quality development. © 2009 Springer Berlin Heidelberg

Quality development in education

The article suggests that people involved in quality development need a specific competence, called quality literacy, in order to successfully improve learning processes. Quality literacy is viewed as a set of competencies that are needed for professional quality development. Quality literacy emphasizes the importance of professionalism as a necessary component for quality development, in addition to structural quality management models. Quality development is a co-production between learners and their learning environment. This means that the educational process can only be influenced and optimized through participation and not steered externally. Quality strategies cannot, therefore, guarantee a high quality of learning processes but rather aim at professionalisation of the educational process. This article suggests participation and negotiation between educational participants (clients and providers) as a main condition for quality development. © 2009 Springer Berlin Heidelberg

Quality development in education

The article suggests that people involved in quality development need a specific competence, called quality literacy, in order to successfully improve learning processes. Quality literacy is viewed as a set of competencies that are needed for professional quality development. Quality literacy emphasizes the importance of professionalism as a necessary component for quality development, in addition to structural quality management models. Quality development is a co-production between learners and their learning environment. This means that the educational process can only be influenced and optimized through participation and not steered externally. Quality strategies cannot, therefore, guarantee a high quality of learning processes but rather aim at professionalisation of the educational process. This article suggests participation and negotiation between educational participants (clients and providers) as a main condition for quality development. © 2009 Springer Berlin Heidelberg

Translation and Cross-Cultural Adaptation of English Version of Kiddy-KINDL to Filipino Language in Assessing the Children\u27s Health-Related Quality of Life (CHRQoL)

Background: Children\u27s health-related quality of life (CHRQoL) involves a child\u27s aim, expectations, standards, or concerns regarding overall health and its domains. The Kiddy-KINDL questionnaire is a tool to measure CHRQoL from information directly derived from children. It has been translated to various languages, except Filipino. This study would provide Filipino healthcare professionals with another functional tool for pediatric evaluation. Objective: To translate the English version of Kiddy-KINDL to Filipino and to determine its validity, test-retest reliability, and internal consistency of the Kiddy-KINDL in assessing the children\u27s health-related quality of life (CHRQoL). Methods: The study involved 3 Phases: Translation, Pilot Testing, and Reliability Phase. The English version of Kiddy-KINDL was cross-culturally adapted and translated into Filipino through a forward and backward translation process. Face validity was performed with 40 participants during the pilot testing phase. Test-retest reliability testing was performed with a total of 116 pairs of children, ages four to six, and their guardian living in Metropolitan Manila. Results: In phases 1 and 2, there were a total of 5 versions before the final Filipino version was considered acceptable. In phase 3, the test-retest reliability score of each dimension ranged from 0.18 to 0.98. The total reliability scores were 0.77 and 0.98 for adults and children, respectively. The internal consistency score was found to be acceptable in both questionnaires. Conclusion: The Filipino-translated Kiddy-KINDL has acceptable face validity results, test-retest reliability, and internal consistency scores

Drug-induced endocrinopathies and diabetes: a combo-endocrinology overview

In the currently overwhelming era of polypharmacy, the balance of the dynamic and delicate endocrine system can easily be disturbed by interfering pharmaceutical agents like medications. Drugs can cause endocrine abnormalities via different mechanisms, including direct alteration of hormone production, changes in the regulation of the feedback axis, on hormonal transport, binding and signaling, as well as similar changes to counter-regulatory hormone systems. Furthermore, drugs can interfere with the hormonal assays, leading to erroneous laboratory results that disorientate clinicians from the right diagnosis. The purpose of this review is to cover a contemporary topic, the drug-induced endocrinopathies, which was presented in the monothematic annual Combo Endo Course 2018. This challenging part of endocrinology is constantly expanding particularly during the last decade, with the new oncological therapeutic agents, targeting novel molecular pathways in the process of malignancies. In this new context of drug-induced endocrine disease, clinicians should be aware that drugs can cause endocrine abnormalities via different mechanisms and mimic a variety of clinical scenarios. Therefore, it is extremely important for clinicians not only to promptly recognize drug-induced hormonal and metabolic abnormalities, but also to address the therapeutic issues for timely intervention

Drug-induced endocrinopathies and diabetes: A combo-endocrinology overview

In the currently overwhelming era of polypharmacy, the balance of the dynamic and delicate endocrine system can easily be disturbed by interfering pharmaceutical agents like medications. Drugs can cause endocrine abnormalities via different mechanisms, including direct alteration of hormone production, changes in the regulation of the feedback axis, on hormonal transport, binding and signaling, as well as similar changes to counter-regulatory hormone systems. Furthermore, drugs can interfere with the hormonal assays, leading to erroneous laboratory results that disorientate clinicians from the right diagnosis. The purpose of this review is to cover a contemporary topic, the drug-induced endocrinopathies, which was presented in the monothematic annual Combo Endo Course 2018. This challenging part of endocrinology is constantly expanding particularly during the last decade, with the new oncological therapeutic agents, targeting novel molecular pathways in the process of malignancies. In this new context of drug-induced endocrine disease, clinicians should be aware that drugs can cause endocrine abnormalities via different mechanisms and mimic a variety of clinical scenarios. Therefore, it is extremely important for clinicians not only to promptly recognize drug-induced hormonal and metabolic abnormalities, but also to address the therapeutic issues for timely intervention. © 2019 European Society of Endocrinology

Drug-induced endocrinopathies and diabetes: A combo-endocrinology overview

In the currently overwhelming era of polypharmacy, the balance of the dynamic and delicate endocrine system can easily be disturbed by interfering pharmaceutical agents like medications. Drugs can cause endocrine abnormalities via different mechanisms, including direct alteration of hormone production, changes in the regulation of the feedback axis, on hormonal transport, binding and signaling, as well as similar changes to counter-regulatory hormone systems. Furthermore, drugs can interfere with the hormonal assays, leading to erroneous laboratory results that disorientate clinicians from the right diagnosis. The purpose of this review is to cover a contemporary topic, the drug-induced endocrinopathies, which was presented in the monothematic annual Combo Endo Course 2018. This challenging part of endocrinology is constantly expanding particularly during the last decade, with the new oncological therapeutic agents, targeting novel molecular pathways in the process of malignancies. In this new context of drug-induced endocrine disease, clinicians should be aware that drugs can cause endocrine abnormalities via different mechanisms and mimic a variety of clinical scenarios. Therefore, it is extremely important for clinicians not only to promptly recognize drug-induced hormonal and metabolic abnormalities, but also to address the therapeutic issues for timely intervention. © 2019 European Society of Endocrinology